ST. LOUIS, Sept. 24 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) today announced that executive management will present at The Fifth Annual JMP Securities Healthcare Conference on Tuesday, September 28, 2010 at 8:30 a.m. ET in New York. Dan Johnston, Chief Financial Officer, will provide an overview of the Company's business strategy and recent corporate developments.
Attendance at this conference is by invitation only. A live audio and slides webcast of Stereotaxis' presentation may be accessed through the Company's website at http://www.stereotaxis.com/Investor-Relations. The replay will be available for 90 days.
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The Stereotaxis system is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The unparalleled clinical capability of Stereotaxis has driven more than 130 hospitals to adopt magnetic navigation for a growing number of complex ablation cases in all four chambers of the heart. Stereotaxis technology is now installed and used by 9 out of the Top 10 Best U.S. Heart Hospitals as ranked by U.S. News and World Report, and more than one third of the EP academic training centers in the United States have included Stereotaxis into their arrhythmia treatmen